Hypertension Canada's 2018 Guidelines for the Management of Hypertension in Pregnancy

Canadian Journal of Cardiology

Volumn 34, Issue 5, 2018, Pages 526-531

  Butalia, Sonia ^a,b   Audibert, Francois ^c   Côté, Anne Marie ^d   Firoz, Tabassum ^e   Logan, Alexander G ^f   Magee, Laura A ^g,h   Mundle, William ⁱ   Rey, Evelyne ^c   Rabi, Doreen M ^a,b   Daskalopoulou, Stella S ^j   Nerenberg, Kara A ^a,b,k  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

^d UNIVERSITÉ DE SHERBROOKE   (Canada)

^e BROWN UNIVERSITY   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g ST THOMAS HOSPITAL   (United Kingdom)

^h KING'S COLLEGE LONDON   (United Kingdom)

ⁱ WINDSOR REGIONAL HOSPITAL   (Canada)

^j MCGILL UNIVERSITY   (Canada)

^k UNIVERSITY OF CALGARY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CANADA; DIASTOLIC BLOOD PRESSURE; EVIDENCE BASED PRACTICE; FEMALE; FETUS OUTCOME; HEALTH CARE PLANNING; HUMAN; MATERNAL HYPERTENSION; MEDICAL SOCIETY; MULTICENTER STUDY (TOPIC); PRACTICE GUIDELINE; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC); SYSTOLIC BLOOD PRESSURE; ADULT; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CLASSIFICATION; COMPLICATION; DEVICES; HEALTH PROMOTION; HYPERTENSION; PREGNANCY; PREGNANCY COMPLICATION; PREVENTIVE HEALTH SERVICE; PROCEDURES; RISK ASSESSMENT; STANDARDS;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; CANADA; EVIDENCE-BASED PRACTICE; FEMALE; HEALTH PROMOTION; HUMANS; HYPERTENSION; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREVENTIVE HEALTH SERVICES; RISK ASSESSMENT;

EID: 85046480388     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2018.02.021     Document Type: Article

References (21)

1. Public Health Agency of Canada. Canadian Chronic Disease Indicators. 2016. Available at: https://infobase.phac-aspc.gc.ca/ccdi-imcc/indicator-details-en.aspx?id=8. Accessed December 29, 2017.
2. Magee, L.A., Pels, A., Helewa, M., et al. Diagnosis, evaluation and management of the hypertensive disorders of pregnancy. Pregnancy Hypertens 4 (2014), 105–145.
3. Ray, J.G., Vermeulen, M.J., Schull, M.J., Redelmeier, D.A., Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 366 (2005), 1797–1803.
4. McDonald, S.D., Malinowski, A., Zhou, Q., Yusuf, S., Devereaux, P.J., Cardiovascular sequelae of preeclampsia / eclampsia: a systematic review and meta-analysis. Am Heart J 156 (2008), 918–930.
5. Mongraw-Chaffin, M.L., Cirillo, P.M., Cohn, B.A., Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension 56 (2010), 166–171.
6. Nerenberg, K., Daskalopoulou, S.S., Dasgupta, K., Gestational diabetes and hypertensive disorders of pregnancy as vascular risk signals: an overview and grading of the evidence. Can J Cardiol 30 (2014), 765–773.
7. Brouwers, M.C., Kho, M.E., Browman, G.P., et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 182 (2010), E839–E842.
8. Leung, A.A., Daskalopoulou, S.S., Dasgupta, K., et al. Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults. Can J Cardiol 33 (2017), 557–576.
9. Tranquilli, A.L., Dekker, G., Magee, L., et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens 4 (2014), 97–104.
10. Martin, J.N., Thigpen, B.D., Moore, R.C., et al. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 105 (2005), 246–254.
11. Magee, L.A., von Dadelszen, P., Singer, J., et al. The CHIPS randomized controlled trial (Control of Hypertension in Pregnancy Study): is severe hypertension just an elevated blood pressure?. Hypertension 68 (2016), 1153–1159.
12. Penny, J.A., Halligan, A.W., Shennan, A.H., et al. Automated, ambulatory, or conventional blood pressure measurement in pregnancy: which is the better predictor of severe hypertension?. Am J Obstet Gynecol 178 (1998), 521–526.
13. Brown, M.A., Mangos, G., Davis, G., Homer, C., The natural history of white coat hypertension during pregnancy. BJOG 112 (2005), 601–606.
14. Denolle, T., Weber, J.L., Calvez, C., et al. Diagnosis of white coat hypertension in pregnant women with teletransmitted home blood pressure. Hypertens Pregnancy 27 (2008), 305–313.
15. Magee, L.A., von Dadelszen, P., Rey, E., et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med 372 (2015), 407–417.
16. Abalos, E., Duley, L., Steyn, D.W., Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev, 2, 2014, CD002252.
17. Magee, L.A., the CHIPS Study Group, von Dadelszen, P., et al. Control of Hypertension In Pregnancy Study randomised controlled trial—are the results dependent on the choice of labetalol or methyldopa?. BJOG 123 (2016), 1135–1141.
18. Barr, M. Jr., Teratogen update: angiotensin-converting enzyme inhibitors. Teratology 50 (1994), 399–409.
19. Swartz, R.H., Cayley, M.L., Foley, N., et al. The incidence of pregnancy-related stroke: a systematic review and meta-analysis. Int J Stroke 12 (2017), 687–697.
20. Leffert, L.R., Clancy, C.R., Bateman, B.T., Bryant, A.S., Kuklina, E.V., Hypertensive disorders and pregnancy-related stroke: frequency, trends, risk factors, and outcomes. Obstet Gynecol 125 (2015), 124–131.
21. Duley, L., Meher, S., Jones, L., Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev, 7, 2013, CD001449.